PHILADELPHIA--(BUSINESS WIRE)--Revitas announced today that Zydus Pharmaceuticals USA, Inc., a globally integrated generic pharmaceutical company, has selected the strategic Revitas™ Flex™ technology platform to support the company’s rapid growth for its US operations. As a generic-only pharmaceutical company, Zydus has chosen the Flex platform to manage contracts, optimize pricing, and ensure compliance through Revitas’s Enterprise Revenue Dynamics (ERD) solutions.
